| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Synergy Life Science Partners L P serves as a 10% Owner at IRTC and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 2 sells. Those positions are worth an estimated $304.7M at current prices.
The biggest single holding is IRTC (~$260.1M) as 10% Owner. The recent filings there lean toward selling, a net 350,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2017 | IRTC Irhythm Holdings, Inc. | 10% Owner | Sell | 350,000 | $37.43 | $13,102,164.03 | -7.8% |